Rotavirus vaccination of very low birth weight infants at discharge from the NICU

Pediatrics

Volumn 132, Issue 3, 2013, Pages

  Stumpf, Katherine A ^a   Thompson, Tami ^b   Sánchez, Pablo J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

Author keywords

Immunization; Neonatal ICU; Preterm infant; Rotavirus

Indexed keywords

ROTAVIRUS VACCINE;

ABSENCE OF SIDE EFFECTS; AGE; ARTICLE; COHORT ANALYSIS; DRUG TOLERABILITY; EXTREMELY LOW BIRTH WEIGHT; FEMALE; HOSPITAL DISCHARGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN INTENSIVE CARE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; ROTAVIRUS INFECTION; UNITED STATES; VACCINATION; VERY LOW BIRTH WEIGHT;

IMMUNIZATION; NEONATAL ICU; PRETERM INFANT; ROTAVIRUS;

ACADEMIC MEDICAL CENTERS; COHORT STUDIES; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; MALE; PATIENT DISCHARGE; PROSPECTIVE STUDIES; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; TEXAS;

EID: 84884582242     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-0291     Document Type: Article

References (17)

1. Bernstein DI. Rotavirus overview. Pediatr Infect Dis J. 2009;28(Suppl 3):S50-S53
2. Cortese MM, Parashar UD; Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2009;58(RR-2):1-25
3. Vesikari T, Matson DO, Dennehy P, et al; Rotavirus Efficacy and Safety Trial (REST) Study Team Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23-33
4. Boom JA, Tate JE, Sahni LC, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010;125 (2). Available at: www.pediatrics.org/cgi/content/full/125/2/e199
5. Newman RD, Grupp-Phelan J, Shay DK, Davis RL. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics. 1999;103 (1). Available at: www.pediatrics.org/cgi/content/full/103/1/e3
6. Dennehy PH, Cortese MM, Bégué RE, et al. A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U. S. children. Pediatr Infect Dis J. 2006;25(12):1123-1131
7. American Academy of Pediatrics Committee on Infectious Diseases. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics. 2009;123(5):1412-1420
8. American Academy of Pediatrics. Rotavirus Infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book 2009: Report of the Committee on Infectious Diseases Elk Grove Village, IL: American Academy of Pediatrics; 2009:576-579
9. Omenaca F, Sarlangue J, Szenborn L, et al; ROTA-054 Study Group. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European infants: a randomized phase IIIb study. Pediatr Infect Dis J. 2012;31(5):487-493
10. Goveia MG, Rodriguez ZM, Dallas MJ, et al; REST Study Team. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J. 2007;26(12):1099-1104
11. Hamilton BE, Hoyert DL, Martin JA, Strobino DM, Guyer B. Annual summary of vital statistics: 2010-2011. Pediatrics. 2013;131(3):548-558
12. Patel MM, Clark AD, Glass RI, et al. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine. 2009;27(22):2916-2922
13. Rothman KJ, Young-Xu Y, Arellano F. Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception. J Infect Dis. 2006;193(6):898; author reply 898-899
14. Simonsen L, Viboud C, Elixhauser A, Taylor RJ, Kapikian AZ. More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis. 2005;192(Suppl 1):S36-S43
15. Rivera L, Peña LM, Stainier I, et al. Horizontal transmission of a human rotavirus vaccine strain-a randomized, placebo-controlled study in twins. Vaccine. 2011;29(51):9508-9513
16. Smith CK, McNeal MM, Meyer NR, Haase S, Dekker CL. Rotavirus shedding in premature infants following first immunization. Vaccine. 2011;29(45):8141-8146
17. Fang AY, Tingay DG. Early observations in the use of oral rotavirus vaccination in infants with functional short gut syndrome. J Paediatr Child Health. 2012;48(6):512-516